Choriocarcinoma (Gestational Trophoblastic Neoplasia) Global Clinical Trials Review, H2, 2018 Summary GlobalData’s clinical trial report, “Choriocarcinoma (Gestational Trophoblastic Neoplasia) Global Clinical Trials Review, H2, 2018”...

Branch Retinal Vein Occlusion Global Clinical Trials Review, H2, 2018 Summary GlobalData’s clinical trial report, “Branch Retinal Vein Occlusion Global Clinical Trials Review, H2, 2018” provides an overview of Branch Retinal...

Chagas Disease (American Trypanosomiasis) Global Clinical Trials Review, H2, 2018 Summary GlobalData’s clinical trial report, “Chagas Disease (American Trypanosomiasis) Global Clinical Trials Review, H2, 2018” provides an overview...

Choroidal Neovascularization Global Clinical Trials Review, H2, 2018 Summary GlobalData’s clinical trial report, “Choroidal Neovascularization Global Clinical Trials Review, H2, 2018” provides an overview of Choroidal Neovascularization...

Brenner Tumor Global Clinical Trials Review, H2, 2018 Summary GlobalData’s clinical trial report, “Brenner Tumor Global Clinical Trials Review, H2, 2018” provides an overview of Brenner Tumor clinical trials scenario. This...

Chediak-Higashi Syndrome Global Clinical Trials Review, H2, 2018 Summary GlobalData’s clinical trial report, “Chediak-Higashi Syndrome Global Clinical Trials Review, H2, 2018” provides an overview of Chediak-Higashi Syndrome...

Competitor Landscape: Sjögren’s Syndrome Summary Sociable Pharma’s ‘Treatment Landscape’ contains evaluations of ongoing development activities within the Sjögren’s Syndrome market, analysis of current & potential future...

Contraceptives: Opportunity Analysis and Forecasts to 2027 Summary Hormonal contraceptives are primarily used to prevent unintended pregnancy; however, some of these contraceptives are also approved or used off-label for other health conditions,...

Vaccines for Emerging Infectious Diseases: Funding, R&D, and Global Partnership Strategies Summary Emerging infectious diseases (EIDs) are characterized by unpredictable incidence and clinical patterns that pose unique challenges for vaccine...

PharmSource – Catching the Next Wave: How Much Have CMOs Benefited from Biosimilars – 2018 Edition Summary Biosimilars are drugs that are highly similar but not identical to branded “innovator” biologics: large molecule,...